Clinical Trial Update: Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the impact of three Hydrafacial treatments on facial skin quality, hydration, and barrier function in adults of all skin types;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutis Laxa
• Xeroderma Pigmentosum

Snippet

Sponsor: Austin Institute for Clinical Research | Conditions: Cutis Laxa Facialis, Xeroderma | Phase 4 | Status: COMPLETED